Literature DB >> 27121646

Three-dimensional polymer scaffolds for enhanced differentiation of human mesenchymal stem cells to hepatocyte-like cells: a comparative study.

Swati Chitrangi1, Prabha Nair2, Aparna Khanna1.   

Abstract

Stem cell-based tissue engineering has emerged as a promising avenue for the treatment of liver diseases and as drug metabolism and toxicity models in drug discovery and development. The in vitro simulation of a micro-environmental niche for hepatic differentiation remains elusive, due to lack of information about crucial factors for the stem cell niche. For generation of functional hepatocytes, an in vivo three-dimensional (3D) micro-environment and architecture should be reproduced. Towards this, we fabricated three scaffolds as dextran-gelatin (DG1), chitosan-hyaluronic acid (CH1) and gelatin-vinyl acetate (GEVAC). Hepatic differentiation of human umbilical cord-derived mesenchymal stem cells (hUC-MSCs) was induced by culturing hUC-MSCs on these scaffolds. The scaffolds support hepatic differentiation by mimicking the native extracellular matrix (ECM) micro-environment and architecture to facilitate 3D cell-cell and cell-matrix interactions. The expression of hepatic markers, glycogen storage, urea production, albumin secretion and cytochrome P450 (CYP450) activity indicated the hepatic differentiation of hUC-MSCs. The differentiated hUC-MSCs on the 3D scaffolds formed hepatospheroids (3D hepatocyte aggregates), as illustrated by scanning electron microscopy (SEM), confocal microscopy and cytoskeleton organization. It was observed that the 3D scaffolds supported improved cell morphology, expression of hepatic markers and metabolic activities, as compared to Matrigel-coated plates. To the best of our knowledge, this is the first report demonstrating the use of a well-characterized scaffold (GEVAC) for enhanced differentiation of hUC-MSCs to hepatocyte-like cells (HLCs).
Copyright © 2016 John Wiley & Sons, Ltd. Copyright © 2016 John Wiley & Sons, Ltd.

Entities:  

Keywords:  F-actin cytoskeleton organization; hepatic differentiation; hepatocyte-like cells (HLCs); hepatospheroid; human umbilical cord-derived mesenchymal stem cells (hUC-MSCs); polymer scaffold; three-dimensional (3D) culture system

Mesh:

Substances:

Year:  2016        PMID: 27121646     DOI: 10.1002/term.2136

Source DB:  PubMed          Journal:  J Tissue Eng Regen Med        ISSN: 1932-6254            Impact factor:   3.963


  6 in total

1.  Microfibrous Scaffolds Enhance Endothelial Differentiation and Organization of Induced Pluripotent Stem Cells.

Authors:  Joseph J Kim; Luqia Hou; Guang Yang; Nicholas P Mezak; Maureen Wanjare; Lydia M Joubert; Ngan F Huang
Journal:  Cell Mol Bioeng       Date:  2017-08-15       Impact factor: 2.321

Review 2.  The clinical application of mesenchymal stem cells in liver disease: the current situation and potential future.

Authors:  Sainan Zhang; Ya Yang; Linxiao Fan; Fen Zhang; Lanjuan Li
Journal:  Ann Transl Med       Date:  2020-04

3.  In vitro Differentiation of Human TERT-Transfected Multi-Lineage Progenitor Cells (MLPC) into Immortalized Hepatocyte-Like Cells.

Authors:  Daniel P Collins; Joel H Hapke; Rajagopal N Aravalli; Clifford J Steer
Journal:  Hepat Med       Date:  2020-06-11

Review 4.  Wharton's Jelly Mesenchymal Stem Cell: Various Protocols for Isolation and Differentiation of Hepatocyte-Like Cells; Narrative Review.

Authors:  Negar Varaa; Saeed Azandeh; Zahra Khodabandeh; Anneh Mohammad Gharravi
Journal:  Iran J Med Sci       Date:  2019-11

Review 5.  Induction and Maturation of Hepatocyte-Like Cells In Vitro: Focus on Technological Advances and Challenges.

Authors:  Ye Xie; Jia Yao; Weilin Jin; Longfei Ren; Xun Li
Journal:  Front Cell Dev Biol       Date:  2021-11-26

6.  Aligned nanofiber scaffolds improve functionality of cardiomyocytes differentiated from human induced pluripotent stem cell-derived cardiac progenitor cells.

Authors:  Mei Ding; Henrik Andersson; Sofia Martinsson; Alan Sabirsh; Anna Jonebring; Qing-Dong Wang; Alleyn T Plowright; Lauren Drowley
Journal:  Sci Rep       Date:  2020-08-11       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.